Prognostic significance of pretreatment PET parameters in inoperable, node-positive NSCLC patients with poor prognostic factors undergoing hypofractionated radiotherapy: a single-institution retrospective study
Pretreatment PET parameters, especially tMTV, hold promise as prognostic indicators in NSCLC patients undergoing hypofractionated radiotherapy. The study highlights the potential of PET metrics as biomarkers for patient stratification.
Authors
- Lukas Käsmann (ORCID: https://orcid.org/0000-0001-6260-5249)
- Chukwuka Eze (ORCID: https://orcid.org/0000-0003-3779-1398)
- Claus Belka (ORCID: https://orcid.org/0000-0002-1287-7825)
- Nina-Sophie Schmidt-Hegemann (ORCID: https://orcid.org/0000-0002-2091-3603)
- Svenja Hering (ORCID: https://orcid.org/0000-0002-5725-9959)
- Adrien Holzgreve (ORCID: https://orcid.org/0000-0002-9566-8438)
- Amanda Tufman (ORCID: https://orcid.org/0000-0001-9243-9050)
- Sina Mansoorian
- Saskia Kenndoff
- Julian Guggenberger
- Julien Dinkel (ORCID: https://orcid.org/0000-0003-1239-6084)
- Niels Reinmuth (ORCID: https://orcid.org/0000-0002-7369-4512)
- Farkhad Manapov
- Annemarie Zinn
Institutions
- German Cancer Research Center (DE)
- Heidelberg University (DE)
- LMU Klinikum (DE)
- München Klinik (DE)
- Asklepios Fachkliniken München-Gauting (DE)
- German Center for Lung Research (DE)
- Deutsches Konsortium für Translationale Krebsforschung (DE)
- Ludwig-Maximilians-Universität München (DE)
Publication Details
- Journal
- EJNMMI Reports
- Published
- 2024-10-07
- DOI
- https://doi.org/10.1186/s41824-024-00220-w
- Citations
- 2
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.84
Funders
- Deutsche Forschungsgemeinschaft